Treatment of High-Risk Moderate Acute Malnutrition Using Expanded Admission Criteria

• Status: Completed
• Trial end date: 2020-06-05
• Target enrollment: 0
• Participant gender: All

Summary

This project explores whether children have better growth and cognitive development when the clinic identifies "higher risk" MAM children and support them either with the same treatment as SAM children or with the recommended practice: nutrition counseling.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Washington University School of Medicine
• Collaborators: Centre for Global Child Health, Hospital for Sick Kids, Toronto, Canada; Department of Psychology, University of Tampere, Finland; Project Peanut Butter, Sierra Leone
• Treatments: Amoxicillin

Criteria

Inclusion Criteria:

• uncomplicated MAM (based on MUAC equal to or greater than 11.5 cm and <12.5)

Exclusion Criteria:

• currently involved in another research trial or feeding program

• medical complication such as oedema, severe nausea/vomiting, severe dehydration, or severe pneumonia

• have a diagnosed or visible sign of developmental delay

• have a history of peanut or milk allergy